Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torasemide versus furosemide in diastolic heart failure with type 2 diabetes
2013-003601-25Phase 3Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes mellitus (T2DM) comparing Torasemide arm with Furosemide arm (2 arms). Started Nov 2013; status: terminated.
02
Drugs
torasemidefurosemide
03
Conditions
heart failure with preserved ejection fraction (HFpEF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-003601-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003601-25.